Menu
Back to User profile » Dr Giampiero Girolomoni
Papers published by Dr Giampiero Girolomoni:
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study
Russo F, Galluzzo M, Stingeni L, Persechino S, Zichichi L, Conti A, Giofrè C, Dini V, Vispi M, Atzori L, Cattaneo A, Parodi A, Bardazzi F, Stinco G, Dapavo P, Girolomoni G, Musumeci ML, Papini M, Venturini M, Dastoli S, Di Nuzzo S, Fargnoli MC, Pagnanelli G, Bernardini N, Gambini DM, Malagoli P, Mazzatenta C, Peris K, Zalaudek I, Fabbrocini G, Loconsole F, Vassallo C, Pietroleonardo L, Prignano F, Franchi C, Offidani AM, Bonifati C, Di Lernia V, Gigante G, Bartezaghi MS, Franchi M, Ursoleo P, Aloisi E
Clinical, Cosmetic and Investigational Dermatology 2023, 16:3561-3574
Published Date: 12 December 2023
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
Gisondi P, Bellinato F, Maurelli M, Geat D, Zabotti A, McGonagle D, Girolomoni G
Psoriasis: Targets and Therapy 2022, 12:213-220
Published Date: 10 August 2022
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules
Bellinato F, Gisondi P, Girolomoni G
Biologics: Targets and Therapy 2021, 15:247-253
Published Date: 29 June 2021
Targeting IL-4 for the Treatment of Atopic Dermatitis
Chiricozzi A, Maurelli M, Peris K, Girolomoni G
ImmunoTargets and Therapy 2020, 9:151-156
Published Date: 29 September 2020
Analysis of drug utilization and health care resource consumption in patients with psoriasis and psoriatic arthritis before and after treatment with biological therapies
Degli Esposti L, Perrone V, Sangiorgi D, Buda S, Andretta M, Rossini M, Girolomoni G
Biologics: Targets and Therapy 2018, 12:151-158
Published Date: 12 November 2018
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
Gisondi P, Girolomoni G
Drug Design, Development and Therapy 2016, 10:1763-1770
Published Date: 25 May 2016
Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation
Colombo GL, Di Matteo S, Bruno G, Girolomoni G, Vena GA
ClinicoEconomics and Outcomes Research 2012, 4:261-268
Published Date: 13 September 2012